Skip to main content
INM logo

INM · InMed Pharmaceuticals Inc.

$1.51 +0.05 (+3.42%)
Market Cap
$4.84M
Shares
3.31M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 10
Total Value: $233,846
Total Shares: 334,207

Institutional Ownership Trend

23 quarters

Holder Concentration

Across 9 13F filers
Top Holder
69.0%
Jun 2023 → Mar 2026 · range 52.7% – 98.9%
of institutional value
Top 5
98.3%
Jun 2023 → Mar 2026 · range 95.5% – 100.0%
of institutional value
Top 10
100.0%
Jun 2023 → Mar 2026 · range 100.0% – 100.0%
of institutional value
HHI
5,057
Jun 2023 → Mar 2026 · range 4,322 – 9,780
Highly concentrated
Showing 10 of 10
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1728328 CUSIP 457637700 13F (30d) 4 filings 4 filers Visit website